SUN1 inhibits osteogenesis and promotes adipogenesis of human adipose‐derived stem cells by regulating α‐tubulin and CD36 expression
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Tingyu Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics & Guangdong Engineering Research Center for Translation of Medical 3D Printi…. Hauptthemen laut MEDLINE: Adipogenesis, CD36 Antigens, Osteogenesis, Tubulin. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, President's Foundation of TCM-Integrated Hospital of Southern Medical University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Sad and UNC84 domain 1 (SUN1) is a kind of nuclear envelope protein with established involvement in cellular processes, including nuclear motility and meiosis. SUN1 plays an intriguing role in human adipose‐derived stem cells (hASCs) differentiation; however, this role remains largely undefined. This study was undertaken to investigate the role of SUN1 in hASCs differentiation, as well as its underlying mechanisms. Employing siRNAs, we selectively downregulated SUN1 and CD36 expression. Microtubules were depolymerized using nocodazole, and PPARγ was activated using rosiglitazone. Western blotting was performed to quantify SUN1, PPARγ, α‐tubulin, CD36, OPN, and adiponectin protein expression levels. Alkaline phosphatase and Oil red O staining were used to assess osteogenesis and adipogenesis, respectively. Downregulated SUN1 expression increased osteogenesis and decreased adipogenesis in hASCs, concomitant with upregulated α‐tubulin expression and downregulated CD36 expression, alongside reduced nuclear localization of PPARγ. Microtubule depolymerization increased CD36 expression. Rescue experiments indicated that microtubule depolymerization counteracted the downregulated SUN1‐induced phenotypic changes. This study demonstrates that SUN1 influences the differentiation of hASCs towards osteogenic and adipogenic lineages, indicating its essential role in cell fate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics & Guangdong Engineering Research Center for Translation of Medical 3D Printing Application & National Virtual & Reality Experimental Education Cen…
- Central Laboratory, Southern Medical University, Guangzhou, China.
- Department of Orthopedics, TCM-Integrated Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Jingxing Dai
Förderung
- National Key R&D Program of China
- President's Foundation of TCM-Integrated Hospital of Southern Medical University
- National Key Research and Development Program of China
Zitieren
APA
Fan, T., Zhu, J., Liu, W., Qu, R., Khan, A. U., Shi, Y., Liu, J., Zhou, Z., Xu, C., Dai, J., & Ouyang, J. (2024). SUN1 inhibits osteogenesis and promotes adipogenesis of human adipose‐derived stem cells by regulating α‐tubulin and CD36 expression. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70143
Vancouver
Fan T, Zhu J, Liu W, Qu R, Khan AU, Shi Y, et al. SUN1 inhibits osteogenesis and promotes adipogenesis of human adipose‐derived stem cells by regulating α‐tubulin and CD36 expression. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70143
BibTeX
@article{Fan2024,
author = {Fan, Tingyu and Zhu, Jinhui and Liu, Wenqing and Qu, Rongmei and Khan, Asmat Ullah and Shi, Yulian and Liu, Jiaxuan and Zhou, Zhitao and Xu, Chujiang and Dai, Jingxing and Ouyang, Jun},
title = {SUN1 inhibits osteogenesis and promotes adipogenesis of human adipose‐derived stem cells by regulating α‐tubulin and CD36 expression},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70143}
}
EUVIMED